PHG
Koninklijke Philips N.V.·Healthcare
28.31
0.640%(+0.18)
Market ClosedLast Updated: — ET
52W L: $21.9552W H: $33.44
PHG NEWS
zacks.com
18h ago
Here's Why Royal Philips (PHG) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
defenseworld.net
5d ago
Koninklijke Philips N.V. $PHG Shares Acquired by JPMorgan Chase & Co.
JPMorgan Chase and Co. increased its holdings in shares of Koninklijke Philips N.V. (NYSE: PHG) by 28.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 112,322 shares of the technology company's stock after acquiring an additional 24,706 shares during
globenewswire.com
Apr 2
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member
April 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the Board of Directors of the Medical Device Innovation Consortium (MDIC). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration (FDA) and other agency partners to help ensure patient access to medical device innovations.
zacks.com
Mar 30
Philips Wins FDA 510(k) Clearance for AI Heart Valve Repair Solution
PHG secures FDA nod for AI-powered EchoNavigator R5.0, boosts its push into minimally invasive heart repair and expands U.S. market reach.
globenewswire.com
Mar 26
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures , supporting treatment [2] DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during one of interventional cardiology's most technically demanding procedures – repairing leaking mitral valves through a minimally invasive approach. DeviceGuide was developed in close collaboration with Edwards Lifesciences, the global leader in structural heart innovation, aligning Philips' imaging and AI expertise with Edwards' expertise in valvular heart therapy development.
zacks.com
Mar 25
Here's Why Royal Philips (PHG) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
